...
首页> 外文期刊>Integrative cancer therapies. >Gene Expression Analysis Reveals the Concurrent Activation of Proapoptotic and Antioxidant-Defensive Mechanisms in Flavokawain B–Treated Cervical Cancer HeLa Cells
【24h】

Gene Expression Analysis Reveals the Concurrent Activation of Proapoptotic and Antioxidant-Defensive Mechanisms in Flavokawain B–Treated Cervical Cancer HeLa Cells

机译:基因表达分析揭示了黄酮素B处理的宫颈癌HeLa细胞中凋亡和抗氧化防御机制的同时激活。

获取原文
           

摘要

Flavokawain B (FKB) is known to possess promising anticancer abilities. This is demonstrated in various cancer cell lines including HeLa cells. Cervical cancer is among the most widely diagnosed cancer among women today. Though FKB has been shown to be effective in treating cancer cells, the exact molecular mechanism is still unknown. This study is aimed at understanding the effects of FKB on HeLa cells using a microarray-based mRNA expression profiling and proteome profiling of stress-related proteins. The results of this study suggest that FKB induced cell death through p21-mediated cell cycle arrest and activation of p38. However, concurrent activation of antioxidant-related pathways and iron sequestration pathway followed by activation of ER-resident stress proteins clearly indicate that FKB failed to induce apoptosis in HeLa cells via oxidative stress. This effect implies that the protection of HeLa cells by FKB from H2O2–induced cell death is via neutralization of reactive oxygen species.
机译:Flavokawain B(FKB)已知具有有希望的抗癌能力。这在包括HeLa细胞在内的各种癌细胞系中得到了证明。宫颈癌是当今女性中诊断最广泛的癌症之一。尽管已证明FKB可有效治疗癌细胞,但确切的分子机制仍未知。这项研究旨在使用基于微阵列的mRNA表达谱和应力相关蛋白的蛋白质组谱来了解FKB对HeLa细胞的影响。这项研究的结果表明FKB通过p21介导的细胞周期停滞和p38激活诱导细胞死亡。但是,同时激活抗氧化剂相关途径和铁螯合途径,然后激活ER驻留应激蛋白的激活清楚地表明,FKB无法通过氧化应激诱导HeLa细胞凋亡。这种效应表明,FKB对HeLa细胞免受H 2 O 2 诱导的细胞死亡的保护是通过中和活性氧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号